Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-07-22

Clinical Trial Update: Feasibility of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency

View source ↗

Summary

Feasibility study evaluating four-dimensional hysterosalpingo-contrast sonography with SonoVue to assess fallopian tube patency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SonoVue (sulfur hexafluoride microbubbles)

Snippet

Sponsor: Peking University First Hospital | Conditions: Four Dimensional Hysterosalpingo-contrast Sonography, Tubal Patency | Status: UNKNOWN